ArticleLeukemia & lymphoma2025

Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.

Jeffrey Baron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.